Dialogue Health Technologies Inc. Logo

Dialogue Health Technologies Inc.

CARE.TO

(1.2)
Stock Price

5,15 CAD

-21.46% ROA

-18.14% ROE

-19.75x PER

Market Cap.

345.692.056,00 CAD

1.52% DER

0% Yield

-18.69% NPM

Dialogue Health Technologies Inc. Stock Analysis

Dialogue Health Technologies Inc. Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Dialogue Health Technologies Inc. Fundamental Stock Analysis
# Analysis Rating
1 DER

The stock has a minimal amount of debt (2%) relative to its ownership, showcasing a strong financial position and lower risk for investors.

2 Revenue Growth

With continuous growth in revenue over the last five years, this company has proven to be a lucrative investment option, showcasing its strong financial performance.

3 Net Profit Growth

Throughout the last three years, this company has experienced consistent net profit growth, reflecting a robust financial performance and making it an attractive investment prospect.

4 ROE

Negative ROE (-18.14%) indicates poor financial performance, raising concerns about profitability and efficiency in utilizing shareholders' equity.

5 ROA

The stock's ROA (-21.46%) indicates that it's not effectively utilizing its assets to generate profits, making it a less favorable option to invest and earn consistent returns.

6 PBV

The stock's high Price-to-Book Value (P/BV) ratio (3.8x) suggests it's overvalued, potentially making it an expensive investment.

7 Assets Growth

Company's revenue has remained stagnant over the past three years, indicating a lack of growth and making it a less favorable option.

8 Graham Number

Based on the Graham number, this company's stock price appears to be higher than its intrinsic value, signaling a potentially unfavorable investment choice.

9 Dividend Growth

Potential investors should be aware that the company's dividend growth has shown no upward trend in the past three years, indicating limited potential for increased returns.

10 Dividend

The company's lack of dividends in the past three years may concern investors seeking regular income.

11 Buffet Intrinsic Value

The company's stock shows signs of being overvalued (-118) according to Warren Buffett's formula, indicating a potential downside as its market price exceeds its estimated intrinsic value.

Dialogue Health Technologies Inc. Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Dialogue Health Technologies Inc. Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Sell
2 MACD Sell
3 RSI Buy
4 Stoch RSI Sell

Dialogue Health Technologies Inc. Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Dialogue Health Technologies Inc. Revenue
Year Revenue Growth
2018 4.012.977
2019 10.088.757 60.22%
2020 35.801.572 71.82%
2021 68.049.313 47.39%
2022 87.132.000 21.9%
2023 102.156.000 14.71%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Dialogue Health Technologies Inc. Research and Development Expenses
Year Research and Development Expenses Growth
2018 2.803.669
2019 3.173.910 11.67%
2020 4.715.248 32.69%
2021 9.515.466 50.45%
2022 10.524.000 9.58%
2023 14.632.000 28.08%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Dialogue Health Technologies Inc. General and Administrative Expenses
Year General and Administrative Expenses Growth
2018 4.930.597
2019 8.690.199 43.26%
2020 20.371.748 57.34%
2021 34.210.214 40.45%
2022 46.063.000 25.73%
2023 51.444.000 10.46%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Dialogue Health Technologies Inc. EBITDA
Year EBITDA Growth
2018 -9.558.956
2019 -11.083.575 13.76%
2020 -18.417.045 39.82%
2021 -23.433.941 21.41%
2022 -21.310.000 -9.97%
2023 -16.044.000 -32.82%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Dialogue Health Technologies Inc. Gross Profit
Year Gross Profit Growth
2018 963.392
2019 5.485.709 82.44%
2020 14.392.950 61.89%
2021 28.806.669 50.04%
2022 43.344.000 33.54%
2023 60.980.000 28.92%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Dialogue Health Technologies Inc. Net Profit
Year Net Profit Growth
2018 -10.083.281
2019 -12.182.559 17.23%
2020 -20.231.100 39.78%
2021 -251.351.388 91.95%
2022 -24.509.000 -925.55%
2023 -23.028.000 -6.43%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Dialogue Health Technologies Inc. Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2018 0
2019 0 0%
2020 0 0%
2021 -4 100%
2022 0 0%
2023 0 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Dialogue Health Technologies Inc. Free Cashflow
Year Free Cashflow Growth
2018 -10.491.628
2019 -13.587.338 22.78%
2020 -19.353.961 29.8%
2021 -24.017.007 19.42%
2022 -16.023.000 -49.89%
2023 -2.241.000 -614.99%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Dialogue Health Technologies Inc. Operating Cashflow
Year Operating Cashflow Growth
2018 -9.735.613
2019 -12.984.677 25.02%
2020 -18.412.054 29.48%
2021 -23.278.997 20.91%
2022 -15.569.000 -49.52%
2023 -2.117.000 -635.43%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Dialogue Health Technologies Inc. Capital Expenditure
Year Capital Expenditure Growth
2018 756.015
2019 602.661 -25.45%
2020 941.907 36.02%
2021 738.010 -27.63%
2022 454.000 -62.56%
2023 124.000 -266.13%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Dialogue Health Technologies Inc. Equity
Year Equity Growth
2018 5.391.777
2019 -6.403.781 184.2%
2020 -31.267.991 79.52%
2021 119.940.725 126.07%
2022 97.351.000 -23.2%
2023 90.857.000 -7.15%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Dialogue Health Technologies Inc. Assets
Year Assets Growth
2018 7.634.016
2019 33.852.507 77.45%
2020 66.374.892 49%
2021 135.252.761 50.93%
2022 119.388.000 -13.29%
2023 111.718.000 -6.87%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Dialogue Health Technologies Inc. Liabilities
Year Liabilities Growth
2018 2.242.239
2019 40.256.288 94.43%
2020 97.642.883 58.77%
2021 15.312.036 -537.69%
2022 22.037.000 30.52%
2023 20.861.000 -5.64%

Dialogue Health Technologies Inc. Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
1.39
Net Income per Share
-0.26
Price to Earning Ratio
-19.75x
Price To Sales Ratio
3.7x
POCF Ratio
-54.46
PFCF Ratio
-52.66
Price to Book Ratio
3.8
EV to Sales
3.4
EV Over EBITDA
-24
EV to Operating CashFlow
-50.17
EV to FreeCashFlow
-48.43
Earnings Yield
-0.05
FreeCashFlow Yield
-0.02
Market Cap
0,35 Bil.
Enterprise Value
0,32 Bil.
Graham Number
2.82
Graham NetNet
0.72

Income Statement Metrics

Net Income per Share
-0.26
Income Quality
0.34
ROE
-0.18
Return On Assets
-0.16
Return On Capital Employed
-0.2
Net Income per EBT
1.04
EBT Per Ebit
0.9
Ebit per Revenue
-0.2
Effective Tax Rate
-0.04

Margins

Sales, General, & Administrative to Revenue
0.47
Research & Developement to Revenue
0.13
Stock Based Compensation to Revenue
0.04
Gross Profit Margin
0.56
Operating Profit Margin
-0.2
Pretax Profit Margin
-0.18
Net Profit Margin
-0.19

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
-0.09
Free CashFlow per Share
-0.1
Capex to Operating CashFlow
0.04
Capex to Revenue
-0
Capex to Depreciation
-0.07
Return on Invested Capital
-0.21
Return on Tangible Assets
-0.21
Days Sales Outstanding
76.42
Days Payables Outstanding
150.68
Days of Inventory on Hand
0
Receivables Turnover
4.78
Payables Turnover
2.42
Inventory Turnover
0
Capex per Share
-0

Balance Sheet

Cash per Share
0,81
Book Value per Share
1,35
Tangible Book Value per Share
0.9
Shareholders Equity per Share
1.35
Interest Debt per Share
0.02
Debt to Equity
0.02
Debt to Assets
0.01
Net Debt to EBITDA
2.1
Current Ratio
3.9
Tangible Asset Value
0,06 Bil.
Net Current Asset Value
0,06 Bil.
Invested Capital
0.02
Working Capital
0,06 Bil.
Intangibles to Total Assets
0.27
Average Receivables
0,02 Bil.
Average Payables
0,01 Bil.
Average Inventory
0
Debt to Market Cap
0

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Dialogue Health Technologies Inc. Dividends
Year Dividends Growth

Dialogue Health Technologies Inc. Profile

About Dialogue Health Technologies Inc.

Dialogue Health Technologies Inc. operates a digital healthcare and wellness platform in Canada Germany, and Australia. Its Integrated Health Platform is a healthcare hub that centralizes its programs in a single user-friendly application, which provide access to psychologists, psychotherapists, social workers, physicians, nurses, and health specialists. The company's platform also enables its members and their dependents to access employee assistance, and occupational health and safety programs. It serves employers and organizations. Dialogue Technologies Inc. was founded in 2016 and is headquartered in Montreal, Canada.

CEO
Mr. Cherif Habib
Employee
240
Address
390 Notre-Dame Street West
Montreal, H2Y 1T9

Dialogue Health Technologies Inc. Executives & BODs

Dialogue Health Technologies Inc. Executives & BODs
# Name Age
1 Mr. Alexis Smirnov
Co-Founder & Chief Technology Officer
70
2 Jennifer Buckley
Senior Vice-Pres of Commercial
70
3 Mr. Navaid Mansuri
Chief Financial Officer
70
4 Mr. Jean-Marc Ayas
Director of Investor Relations
70
5 Melissa Azuelos
Gen. Counsel
70
6 Mr. Jean-Nicolas Guillemette
Chief Operating Officer
70
7 Jean-Christophe de Le Rue
Director of Public & Gov. Relations
70
8 Mr. Cherif Habib
Co-Founder, Chief Executive Officer & Director
70
9 Lilian Lau
Vice President of Marketing
70
10 Randy Wetmore
Vice President of Sales
70
11 Ms. Nathalie Delisle
Gen. Counsel, Corporation Sec. & Chief Privacy Officer
70
12 Darryl Campbell
Chief Information Security Officer
70

Dialogue Health Technologies Inc. Competitors